Drug profile

The FDA adverse-event record for Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31

196 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31. See the species affected, top reactions, and outcomes below.

196
adverse-event reports
10.2%
death-coded share
Dog
most-reported species
61
Lethargy (see also Central nervous system depression in 'Neurological') - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
196
Total Reports
20
Deaths Reported
10.2%
Death Rate

Active Ingredients

Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31

Administration Routes

SubcutaneousUnknown

Species Affected

Dog 196

Most Affected Breeds

Retriever - Labrador 25
Shih Tzu 12
Terrier - Bull - American Pit 10
Terrier - Yorkshire 10
Retriever - Golden 9
Boxer (German Boxer) 8
Terrier - Jack Russell 7
Crossbred Canine/dog 6
Beagle 6
Chihuahua 6

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 61
Vomiting 57
Anorexia 36
Anaphylactoid reaction 34
Other abnormal test result NOS 25
Facial swelling (see also 'Skin') 22
Diarrhoea 22
Urticaria 19
Emesis 15
Lameness 15
Injection site swelling 14
Fever 14

Outcome Breakdown

Ongoing
107 (54.6%)
Recovered/Normal
60 (30.6%)
Euthanized
13 (6.6%)
Outcome Unknown
9 (4.6%)
Died
7 (3.6%)

Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31 Adverse Event Insights

196 reports name Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31; 20 recorded a death outcome (10.2% of reported events, not a population-level mortality rate). Active ingredient: Borrelia Burgdorferi Strain Ips 930-34-081596; Borrelia Burgdorferi Strain B-31. Administration routes: Subcutaneous, Unknown.

By species: Dog (196 reports). By breed: Retriever - Labrador (25), Shih Tzu (12), Terrier - Bull - American Pit (10).

Leading clinical signs: Lethargy (see also Central nervous system depression in 'Neurological') (61), Vomiting (57), Anorexia (36), Anaphylactoid reaction (34). Outcome, 196 coded reports: Ongoing leads at 54.6%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.